Kolexia
Etienne Gabriel Médecine interne
Etienne Gabriel
Médecine interne
Institut Bergonié
Bordeaux, France
231 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémie myéloïde chronique BCR-ABL positive Leucémies Leucémie myéloïde Leucémie myéloïde en phase chronique Syndromes myéloprolifératifs Chromosome Philadelphie Myélofibrose primitive Crise blastique Maladies de la moelle osseuse

Collaborateurs

Voir plus
Nicolini Franck
Nicolini Franck
Centre Léon-Bérard, Lyon, France
Mahon Francois-Xavier
Mahon Francois-Xavier
Institut Bergonié, Bordeaux, France
Rea Delphine
Rea Delphine
Hôpital Saint-Louis, Paris, France
Huguet Francoise
Huguet Francoise
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France

Industries

Voir plus
Novartis
76 collaboration(s)
Dernière en 2023
Pfizer
19 collaboration(s)
Dernière en 2023
Incyte
8 collaboration(s)
Dernière en 2023
BMS
3 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
BIO-TIMER: Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated With Targeted Therapy: the Model of Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.
Essai Clinique (CHU Clermont-Ferrand)   29 février 2024
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients.
British journal of haematology   07 février 2024
CML: A Phase 1a/1b Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia
Essai Clinique (Enliven Therapeutics)   09 janvier 2024
MonSThr: Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr)
Essai Clinique (CHU Bordeaux)   12 décembre 2023
Optimizing the use of bosutinib in patients with chronic-phase chronic myeloid leukemia: Recommendations of a panel of experts from the Fi-LMC (French CML working group).
Bulletin du cancer   11 décembre 2023
CLOJAK: Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)
Essai Clinique (CHU Bordeaux)   09 novembre 2023
Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure: A Report from the Residiag Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Characteristics, Outcomes, Tfr Rates in Young Adults with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: A French Observational Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO): A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (DUO)
Essai Clinique (SecuraBio)   07 septembre 2023